A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...

distinguished for integrating advanced technology into its CGM products. The Medtronic Guardian Connect system not only monitors glucose levels but also utilizes predictive algorithms to forewarn ...

Medtronic is hoping that their efforts in the AID and "smart dosing" markets will pay off after largely missing out on the CGM market. They may be onto something. The recent ADA guidelines do ...

New Medtronic CFO Thierry Piéton. [Image from Mobilize Financial Services] Medtronic (NYSE: MDT) + announced today that it appointed Thierry Piéton as its new chief financial officer (CFO ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other best dividend stocks to buy and hold. In recent years, many investors have shifted their focus ...

Since the start of 2025, Medtronic plc (NYSE:MDT) has surged by nearly 10%. Earlier this year, the company secured US approval for its Simplera continuous glucose monitoring (CGM) system.

Another neuromodulation innovation to watch for in the pipeline is Medtronic’s tibial implant for overactive bladder. Smart dosing for diabetes patients “is expected to dominate by the end of the ...